CVS Health’s iShares iBoxx $ High Yield Corporate Bond ETF HYG Stock Holding History

CVS Health’s Portfolio HYG Stock Details HYG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.2M	Buy	+90,000	New	+$7.2M	3.2%	11

Other funds holding HYG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCMG

Clark Capital Management Group Philadelphia, Pennsylvania $18.3B AUM 36.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JSTA

Japan Science & Technology Agency Tokyo, Japan $5.29B AUM 8.96% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

AAMU

APG Asset Management US New York $14.3B AUM 16.79% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

CVS Health's HYG Position: Q2 2026 in Review

CVS Health opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF (HYG) in Q2 2026: 90,000 shares worth $7.2M. The stake represents 3.2% of the portfolio and ranks #11 among its holdings.

983 funds tracked by Wall St. Rank hold HYG as of Q2 2026.

CVS Health held 90,000 shares of iShares iBoxx $ High Yield Corporate Bond ETF worth $7.2M as of Q2 2026.
iShares iBoxx $ High Yield Corporate Bond ETF was a new CVS Health position in Q2 2026.
iShares iBoxx $ High Yield Corporate Bond ETF made up 3.2% of CVS Health's portfolio in Q2 2026, its #11 holding.
983 funds tracked by Wall St. Rank held iShares iBoxx $ High Yield Corporate Bond ETF as of Q2 2026.

Based on CVS Health's 13F filing for Q2 2026, filed 6 Aug 2026.